These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 27837968)

  • 1. Label-Free Measurements of Tenofovir Diffusion Coefficients in a Microbicide Gel Using Raman Spectroscopy.
    Chuchuen O; Maher JR; Simons MG; Peters JJ; Wax AP; Katz DF
    J Pharm Sci; 2017 Feb; 106(2):639-644. PubMed ID: 27837968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Label-free analysis of tenofovir delivery to vaginal tissue using co-registered confocal Raman spectroscopy and optical coherence tomography.
    Chuchuen O; Maher JR; Henderson MH; Desoto M; Rohan LC; Wax A; Katz DF
    PLoS One; 2017; 12(9):e0185633. PubMed ID: 28961280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaginal deployment and tenofovir delivery by microbicide gels.
    Gao Y; Yuan A; Chuchuen O; Ham A; Yang KH; Katz DF
    Drug Deliv Transl Res; 2015 Jun; 5(3):279-94. PubMed ID: 25874971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of microbicide concentrations in fluids, gels and tissues using confocal Raman spectroscopy.
    Chuchuen O; Henderson MH; Sykes C; Kim MS; Kashuba AD; Katz DF
    PLoS One; 2013; 8(12):e85124. PubMed ID: 24386455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Full depth measurement of tenofovir transport in rectal mucosa using confocal Raman spectroscopy and optical coherence tomography.
    Presnell AL; Chuchuen O; Simons MG; Maher JR; Katz DF
    Drug Deliv Transl Res; 2018 Jun; 8(3):843-852. PubMed ID: 29468424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semi-solid gels function as physical barriers to human immunodeficiency virus transport in vitro.
    Lai BE; Geonnotti AR; Desoto MG; Montefiori DC; Katz DF
    Antiviral Res; 2010 Nov; 88(2):143-51. PubMed ID: 20709109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity Analysis of a Pharmacokinetic Model of Vaginal Anti-HIV Microbicide Drug Delivery.
    Jarrett AM; Gao Y; Hussaini MY; Cogan NG; Katz DF
    J Pharm Sci; 2016 May; 105(5):1772-1778. PubMed ID: 27012224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a combination microbicide gel formulation containing IQP-0528 and tenofovir for the prevention of HIV infection.
    Ham AS; Ugaonkar SR; Shi L; Buckheit KW; Lakougna H; Nagaraja U; Gwozdz G; Goldman L; Kiser PF; Buckheit RW
    J Pharm Sci; 2012 Apr; 101(4):1423-35. PubMed ID: 22227864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coupled gel spreading and diffusive transport models describing microbicidal drug delivery.
    Funke C; MacMillan K; Ham A; Szeri AJ; Katz DF
    Chem Eng Sci; 2016 Oct; 152():12-20. PubMed ID: 28042165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Raman spectroscopy as a tool for measuring mutual-diffusion coefficients in hydrogels.
    Kwak S; Lafleur M
    Appl Spectrosc; 2003 Jul; 57(7):768-73. PubMed ID: 14658654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-Time Analysis of Tenofovir Release Kinetics Using Quantitative Phosphorus (
    Agrahari V; Meng J; Purohit SS; Oyler NA; Youan BC
    J Pharm Sci; 2017 Oct; 106(10):3005-3015. PubMed ID: 28414145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Squeezing flows of vaginal gel formulations relevant to microbicide drug delivery.
    Kieweg SL; Katz DF
    J Biomech Eng; 2006 Aug; 128(4):540-53. PubMed ID: 16813445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimuli-sensitive thiolated hyaluronic acid based nanofibers: synthesis, preclinical safety and in vitro anti-HIV activity.
    Agrahari V; Meng J; Ezoulin MJ; Youm I; Dim DC; Molteni A; Hung WT; Christenson LK; Youan BC
    Nanomedicine (Lond); 2016 Nov; 11(22):2935-2958. PubMed ID: 27785967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering of a hybrid polymer-lipid nanocarrier for the nasal delivery of tenofovir disoproxil fumarate: physicochemical, molecular, microstructural, and stability evaluation.
    Pokharkar VB; Jolly MR; Kumbhar DD
    Eur J Pharm Sci; 2015 Apr; 71():99-111. PubMed ID: 25708940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of tenofovir-UC781 combination microbicide vaginal gels.
    Kiser PF; Mahalingam A; Fabian J; Smith E; Damian FR; Peters JJ; Katz DF; Elgendy H; Clark MR; Friend DR
    J Pharm Sci; 2012 May; 101(5):1852-64. PubMed ID: 22359356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic modeling of a gel-delivered dapivirine microbicide in humans.
    Halwes ME; Steinbach-Rankins JM; Frieboes HB
    Eur J Pharm Sci; 2016 Oct; 93():410-8. PubMed ID: 27559026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Phase 1 Randomized, Blinded Comparison of the Pharmacokinetics and Colonic Distribution of Three Candidate Rectal Microbicide Formulations of Tenofovir 1% Gel with Simulated Unprotected Sex (CHARM-02).
    Hiruy H; Fuchs EJ; Marzinke MA; Bakshi RP; Breakey JC; Aung WS; Manohar M; Yue C; Caffo BS; Du Y; Abebe KZ; Spiegel HM; Rohan LC; McGowan I; Hendrix CW
    AIDS Res Hum Retroviruses; 2015 Nov; 31(11):1098-108. PubMed ID: 26227279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deducing Mucosal Pharmacokinetics and Pharmacodynamics of the Anti-HIV Molecule Tenofovir from Measurements in Blood.
    Govil S; Katz DF
    Sci Rep; 2019 Jan; 9(1):82. PubMed ID: 30643165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of inhomogeneous boundary dilution on the coating flow of an anti-HIV microbicide vehicle.
    Tasoglu S; Peters JJ; Park SC; Verguet S; Katz DF; Szeri AJ
    Phys Fluids (1994); 2011 Sep; 23(9):93101-931019. PubMed ID: 21998495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maximized mucoadhesion and skin permeation of anti-AIDS-loaded niosomal gels.
    Zidan AS; Habib MJ
    J Pharm Sci; 2014 Mar; 103(3):952-64. PubMed ID: 24464823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.